Background: Type 2 DM has been linked with dyslipideamia and elevation of some liver enzymes, in fact it has been identified as independent risk factor for development of coronary artery disease (CHD). The risk of coronary heart disease in patients with type 2 DM with hepatic involvement was assessed in this study. 
INTRODUCTION
In the health care delivery system worldwide, cases of diabetes mellitus (DM) and its associated clinical conditions are increasing on daily basis. It is present in about 4% of the world population; this has been estimated to be 143 million individuals and there is speculation to increase to 300 million by the year 2025 (Jelena et al., 2010) . These increments are pronounced more in underdeveloped countries (Khing et al., 1998) . Prevalence of 2-4% has been reported in Nigeria (Sanni et al., 2010; Owoaje et al., 1997) . Type 2 DM is a heterogeneous, multifactorial, polygenic disease characterized by a defect in insulin secretion (the beta cell secretory defect) and action (insulin resistance) which results in elevated blood glucose (Hayden, 2000; Hayden and Tyagi, 2002) . Type 2 DM has been linked with dyslipideamia and elevation of some liver enzymes, in fact it has been identified as independent risk factor for development of coronary artery disease (CHD) (Gracia et al., 1974; Demacker et al., 2000) . In view of morbidity and mortality associated with DM it will be interesting to assess patients bearing in mind the accompanying complications. Lipid profile and liver enzymes assay in patients with this condition should be paramount to health care givers.
Lipid profile remains one of the utmost ways of assessing patients suspected to having risk of developing CHD in this environment. Type 2 DM is associated with abnormalities of both quantity and quality of lipoproteins that, among other factors, might be responsible for the increased incidence of CHD (Assman et al., 1988) . In a study by Jelena et al. (2010) and Ganda et al. (1979) in patients with type 2 DM, High Density Lipoprotein Cholesterol (HDL-C) was lower in both sexes and there is significant higher levels of Total cholesterol (TC) and Low Density Lipoprotein cholesterol (LDL-C) in women. However, some other reports observed no change in TC and LDL-C levels when compared to the general population (Demacker et al., 2000; Nikkila et al.,1977) . Furthermore, hyperlipidaemia has been reported in patients with type 2 DM as well as in individual engaging in the consumption of high fat diet (Puir et al., 1994; Gulla et al., 2011) . This dyslipideamia observed in type 2 DM is also associated with abnormality of liver enzymes and could be a direct pathology resulting from DM itself. Recently Non-Alcoholic Fatty Liver Disease (NAFLD) is now a recognized pathogenic factor in type 2 DM (Schindhelm et al., 2006) .
The liver helps to maintain normal blood glucose concentration in the system (Lewis et al., 2002) . This function is deranged in association with liver enzymes abnormality in type 2 DM and in obese individual (Puir et al., 1994) . It helps to predict any form of metabolic insult to the liver. Elevated serum ɣ-Glutamine Transferase (GGT) in type 2 DM is associated with increased risk of cardiovascular disease (Nakanishi et al., 2004) , though the most common abnormality of liver function test seen in type 2 DM is elevated Alanine Transaminases (ALT) (Marcherini et al., 2001) .
Despite the effect of type 2 DM on liver enzymes and lipid profile, some other factors like alcohol intake and diet habit also have some effects (Gulla et al., 2011) . This study was therefore designed to determine the serum level of TC, HDL-C, LDL-C, Triglyceride (TG), Aspartate Transaminases (AST), ALT, Alkaline Phosphatase (ALP), and fasting plasma glucose (FPG) type 2 DM patients seen in osogbo, Nigeria.
MATERIALS AND METHODS
The study was carried out in the Department of Chemical Pathology of Ladoke Akintola University of Technology Teaching Hospital, Osogbo. A pool of samples request for liver enzymes for over six months were carefully selected from our freezer and lipid profile analysis was done on those diagnosed to having type 2 DM. These set of selected patients were followed up to their records for proper extraction of data. Similarly control samples were selected. A total of 166 subjects were gotten out of which 106 were normo-tensive diabetic subjects (FPG>7.0mmol/l); and 60 aged matched normotensive controls with normal FPG (2.5-5.5mmol/l) were recruited into the study. Patients who in their records were alcoholic, positive for hepatotoxic viruses, hypertensive and those on lipid lowering drugs were excluded from this study. All diabetic subjects were diagnosed at least 2 years before recruitment into the study and were on insulin and/or oral hypoglycaemic agents as at the time samples were taken for the analysis.
TC, LDL-C, HDL-C and TG were determined using kit based on enzymatic method from Randox laboratotry, Aldren, USA, also FPG was determined using kit based on glucose oxidase method from the same company. AST, ALT and ALP were analyzed using kit based on kinetic method, also from the same company. Results obtained were analyzed with the aid of SPSS setting level of significance at p ≤0.05. Table III shows correlation between the liver enzymes and the lipid profile among the diabetic subjects. A weak positive significant correlation between FPG and AST (r=0.268, p<0.05), TC and ALP (r=0.273, p<0.05), LDL and ALP (r=0.301, p<0.05) was observed. However a weak negative significant correlation exist between HDL/TC and ALP (r=0.201, p<0.05).
RESULTS
Weak positive significant correlation also exist between BMI and LDL (r=0.232, p<0.05); ALT and ALP (r=0.210, p<0.05), ALP and AST (r=0.391, p<0.05) whereas weak negative significant correlation exist between TC and HDL/TC (r=0.2730.353, p<0.05); HDL and TG (r=0.201, p<0.05); TG and HDL/TC (r=0.298, p<0.05). A strong negative significant correlation was found between TC and LDL (r=0.896, p<0.05) as well as in LDL and HDL/TC(r=0.588, p<0.05). Another strong significant correlation though positive exists between AST and ALT (r=0.686, p<0.05); HDL and HDL/TC(r=0.765, p<0.05).
DISCUSSION
Liver helps in regulating metabolisms including maintenance of normal blood glucose concentration in fasting and postprandial states. With loss of insulin effect on the liver, there is promotion of glycogenolysis leading to increase hepatic glucose production and lipolysis leading to abnormal triglyceride and excess fatty acid production. Abnormalities of triglyceride storage and lipolysis in insulin-sensitive tissues such as the liver are an early manifestation of conditions characterized by insulin resistance and are detectable earlier than fasting hyperglycemia. Our findings on liver enzymes are similar to previous studies (Erbey et al., 2000; Colditz et al., 1995) . AST, ALT and ALP were all significantly elevated compared with controls, this could be due to direct hepatotoxic effect of fatty acid on the liver when it is produced in excess. Mechanisms for this may include cell membrane disruption at high concentration, mitochondrial dysfunction, toxin formation, and activation and inhibition of key steps in the regulation of metabolism. Other potential explanations for elevated transaminases in insulin-resistant states include oxidantive stress from reactive lipid peroxidation, peroxisomal beta-oxidation, and recruited inflammatory cells. The insulinresistant state is also characterized by an increase in pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), which may also contribute to hepato-cellular injury. It is also hypothesized that the elevated ALT, a gluconeogenic enzyme whose gene transcription is suppressed by insulin, could indicate an impairment in insulin signalling rather than purely hepatocyte injury (Chan et al., 1994) . However, ALT elevation could also have been due to overweight (Harris, 2005) but in our study both subjects and controls are overweight.
Although the role of elevated total cholesterol that has been observed in type 2 DM is not well understood (Jelena et al., 2010; ganda et al., 1979) . In our study there is significant elevation in total cholesterol when compared with controls. Elevated TG in diabetic subjects in our study compare to the control is in consistent with a report of Lewis et al. (2002) and this has been observed to be a detectable finding before fasting hyperglycemia in type 2 DM. There was also a reduction of HDL in subjects compared with controls but not statistically significant, this also reflected from lower HDL/TC ratio, it is consistent with observation from previous similar study by Steven et al. (1998) . Another important finding in the study is the higher level of plasma LDL in diabetic subjects which is in consistent with findings in some previous studies (Nikkila et al. ,1977; Steven et al., 1998) . This has been suggested to be as a result of lipolysis that results from insulin resistance that is the underlined pathology in type 2 diabete mellitus.
CONCLUSION
There are evidences of dyslipidaemia and elevated liver enzymes in type 2 DM patients seen in Osogbo, Nigeria.
